Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity

Summary

The purpose of this study is to test whether ACULAR, a nonsteroidal anti-inflammatory eye drop medication, can prevent the development of retinopathy of prematurity (ROP) and/ or decrease its severity.In this study ACULAR will be compared to a placebo (artificial tear). The hypothesis would be that ACULAR treatment will decrease the incidence of moderate to severe ROP (grade II and above)by 50%.

Timeline

Start

2005-11

Primary completion

2008-08

Completion

2008-08

Drugs

Indications